Dermatological therapeutics are pharmaceuticals that specifically address skin disorders such as psoriasis, melanoma of skin, and other bacterial as well as fungal infections. Acne is the largest market segment of the dermatological diagnostics market accounting for ~30% of the total therapeutics market followed by psoriasis (~25%), rosacea (~15%), and atopic dermatitis (~10%) Skin cancer is the most common cancer in the United States, It is estimated that more than 8,500 people are diagnosed with skin cancer every day in United States itself. Atopic dermatitis affects at least 28 million people of all ages in U.S.
Market analysis in this report provides insight on major players in dermatology diagnostic devices and therapeutics that are operating in the market. It helps the new players to understand the business models and identify the product lines of the specific companies to establish in diagnostic devices and therapeutics market. The increasing investment in R&D of therapeutics, increasing expenditure in healthcare, unmet need for efficacious drug and growing competition for new drugs are key factors propelling the growth of the market. However, increasing cost of R&D, drugs going off patent, increasing generic products, and high cost of therapy are turning out to be restraints for the market.
The Dermatological therapeutics market have been segmented based on the type of therapeutics, application and geography. The Dermatological therapeutics have been segmented based on the type of therapeutics and it is classified into alopecia, herpes, psoriasis, rosacea, atopic dermatitis, acne vulgaris. The class on type of application includes the market dermoscopy, patch testing, skin biopsy, culture, phototests, and morbidity/prevalence. It is also segmented based on therapeutic procedures into Anti-infectives, Corticosteroids, Anti Psoriasis, Anti-acne, Topical and other Dermatological Drugs.
This report have been geographically segmented into North America, Europe, Asia-Pacific, Middle East & Africa and South America. The North American region have been further segmented into USA, Canada and Mexico. The Europe region have been sub-divided into Germany, France, UK, Spain, Italy, Scandinavia, Benelux and Rest of Europe. The Asia-Pacific market have been segmented into Japan, China, India, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East & African market have been subdivided into GCC countries, South Africa and rest of Middle East and Africa. The South American market have been segmented into Brazil, Argentina and rest of South America. North America accounts for the largest market share.
The current market has drugs whose patents are expiring, new drugs coming to the picture will be a great opportunity for the market. The key players in the market are Allergan Inc, Chester Valley Pharmaceuticals Inc, Eisai Inc., Dermik Laboratories Inc, Genentech Inc., Onset Therapeutics, AGI Dermatics, Amgen Inc., Medicis Pharmaceutical Corp, Ferndale Laboratories Inc., Sinclair Pharmaceuticals, Valeant Pharmaceuticals International, Skinmedica Inc., Schering-Plough Corp, Prime Pharmaceuticals Corp, Summers Laboratories Inc.
Market analysis for the Global Dermatological therapeutics market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global Dermatological therapeutics market
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
1.1 Study deliveratives
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecasr period years
1.6 General Study Assumptions
2. RESEARCH METHODOLOGY
2.2 Analysis Methodology
2.3 Study timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current market scenario
5.2 Porters Five Force Analysis
5.2.1 Bargaining Power of suppliers
5.2.2 Bargaining power of buyers
5.2.3 Degree of competition
5.2.4 Threat of substitution
5.2.5 Threat of new entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Increase in the Elderly Population
6.1.2 Increase in Incidence Rates for Dermatology Diseases
6.1.3 Increase in Awareness Levels of Disease Progression and Etiology
6.1.4 Expiry of existing patents
6.2 Market Restraints
6.2.1 Generics , problem for primary manufacturers
6.2.2 Serious Side Effects for Certain Classes of Therapeutic drugs
6.3 Market opportunities
6.3.1 Patent expiry of major drugs
6.4 Key Challenges
6.4.1 Competition between firms
7. GLOBAL DERMATOLOGY THERAPEUTICS MARKET -SEGMENTATION
7.1 BASED ON TYPE OF THERAPEUTICS
7.1.5 ATOPIC DERMATITIS
7.1.6 ACNE VULGARIS
7.2 BASED ON TYPE OF APPLICATION
7.2.2 PATCH TESTING
7.2.3 SKIN BIOPSY
7.3 BASED ON TYPE OF THERAPEUTIC PROCEDURES
7.3.5 TOPICAL AND DERMATOLOGICAL DRUGS
8. Global Dermatology Therapeutics market by Geography - Regional shares and forecast
8.1 North America
8.1.1 United States
8.2.5 Spain & Portugal
8.2.8 Rest of Europe
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.2 South Africa
8.4.3 Rest of Middle East and Africa
8.5 Latin America
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 Allergan Inc
10.2 Eisai Inc.
10.3 Dermik Laboratories Inc
10.4 Genentech Inc.
10.5 Onset Therapeutics
10.6 AGI Dermatics
10.7 Amgen Inc.
10.8 Chester Valley Pharmaceuticals Inc
10.9 Medicis Pharmaceutical Corp
10.10 Ferndale Laboratories Inc.
10.11 Sinclair Pharmaceuticals
10.12 Valeant Pharmaceuticals International
10.13 Skinmedica Inc.
10.14 Schering-Plough Corp
10.15 Prime Pharmaceuticals Corp
10.16 Summers Laboratories Inc
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market